Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. (2018)
Attributed to:
Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.00344-18
PubMed Identifier: 29941636
Publication URI: http://europepmc.org/abstract/MED/29941636
Type: Journal Article/Review
Volume: 62
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 9
ISSN: 0066-4804